5.2. Analysis.
Comparison 5: Inhaled aztreonam lysine (AZLI) versus tobramycin for inhalation solution (TIS), Outcome 2: FEV1 % predicted ‐ mean actual change from baseline
Comparison 5: Inhaled aztreonam lysine (AZLI) versus tobramycin for inhalation solution (TIS), Outcome 2: FEV1 % predicted ‐ mean actual change from baseline